AlphaCrest Capital Management LLC
- SEC CIK
- 0001633256
- Latest filing
- Jan 27, 2023
TGTX holding history
TG Therapeutics, Inc. in every 13F filed by AlphaCrest Capital Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TGTX overviewAll 13F holders of TGTXFull Q4 2022 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −77,224−100.0% | Sold out | Holders |
| Q2 2022 | 77,224 | $328.0K | <0.1% | −6,700−8.0% | Reduced | Holders |
| Q1 2022 | 83,924 | $798.0K | <0.1% | +67,714+417.7% | Added | Holders |
| Q4 2021 | 16,210 | $308.0K | <0.1% | +16,210 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −27,227−100.0% | Sold out | Holders |
| Q2 2021 | 27,227 | $1.06M | <0.1% | +27,227 | New | Holders |